Company / Revenue
Glaukos Corp. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$507.4M
FY2025
5-year range
$282.9M / $507.4M
FY2021-FY2025
Trend
+32.3%
vs FY2024
Sector context
#117 of 150
Health Care
What the data says
Glaukos Corp.'s revenue of $507M is lower than 78% of companies in the Health Care sector (FY2025). Revenue has increased for 3 consecutive years, from $283M in FY2022 to $507M in FY2025.
Based on SEC 10-K filings.
$507M in FY2025 with a 5-year CAGR of +17.7%.
Improved from $315M to $507M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +21.5%
- 5-Year CAGR
- +17.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 150This company $507.4M Sector average $19.5B
▼
-97.4% below sector average
Key checks
Key Insights
- Glaukos Corp.'s revenue has grown for 3 consecutive years.
- 5-year CAGR of +17.7%, indicating consistent growth.
- In FY2025, revenue increased 32.3% year-over-year.
- Ranks #117 out of 150 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $507.4M | +32.3% |
| FY2024 | $383.5M | +21.9% |
| FY2023 | $314.7M | +11.3% |
| FY2022 | $282.9M | -3.8% |
| FY2021 | $294.0M | +30.7% |
| FY2020 | $225.0M | -5.1% |
| FY2019 | $237.0M | +30.7% |
| FY2018 | $181.3M | +13.8% |
| FY2017 | $159.3M | +39.2% |
| FY2016 | $114.4M | +59.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026